Search Results 2081-2090 of 19715 for Hemoglobin

1. A Study to Evaluate Safety and Effectiveness of SHP647 as Induction Therapy in Participants with Moderate-to- Severe Crohn's Disease - Mayo Clinic

   Total bilirubin level ≥ 1.5 x ULN or > 2.0 x ULN if the subject has a known documented diagnosis history of Gilbert's syndrome). Hemoglobin level ≤ 80 g/L ( ...

2. Clinical trials - Oncology (Medical)

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

3. Clinical trials - Oncology (Medical)

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

4. Clinical trials - Oncology (Medical)

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

5. Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma - Mayo Clinic

   * Hemoglobin > 9.0 g/dL (within 28 days prior to registration) * Absolute neutrophil count ≥ 1.5 x 10^3/uL (within 28 days prior to registration)

6. Atezolizumab Immunotherapy in Patients With Advanced NSCLC (AJCC 7th Edition) - Mayo Clinic

   Hemoglobin ≥ 10.0 g/dL;; Total bilirubin ≤ 1.5 x upper limit of normal (ULN) with the following exception: Patients with known Gilbert disease who have ...

7. Publications - Nicholas A. Bedard, M.D. - Mayo Clinic

   Prospective Noninvasive Hemoglobin Monitoring in the Outpatient Total Joint Arthroplasty Setting. J Bone Joint Surg Am. 2025 Feb 19; 107 (4):364-371 Epub ...

8. Induction Therapy With RO7790121 in Patients With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

   Hemoglobin < 8 g/dL. Absolute lymphocyte count < 500/uL. Prohibited Medications Exclusion Criteria. Any of the following related to previous or current ...

9. A Study to Evaluate HH2853 in Patients with Relapsed/Refractory Non-Hodgkin's Lymphomas or Advanced Solid Tumors - Mayo Clinic

   not calculated) should meet this criterion. 4. Platelets ≥ 1 x LLN (no Platelet transfusion for 7 days prior to screening) 5. Hemoglobin (Hgb) ≥ 9 g/dL ...

10. Hematology - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...